Concerns
AstraZeneca vaccine
Blood clot
Business Day
Concerns
Global
Guardian
Health
Premium Times
Uncategorized
Canada Pauses AstraZeneca Vaccine for People Under 55 Over Blood Clot Concerns
Canada has suspended the use of the Oxford-AstraZeneca coronavirus vaccine for people under age 55 following concerns it might be linked to rare blood clots. The National Advisory Committee on

